BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34769351)

  • 1. Multi-Run Concrete Autoencoder to Identify Prognostic lncRNAs for 12 Cancers.
    Al Mamun A; Tanvir RB; Sobhan M; Mathee K; Narasimhan G; Holt GE; Mondal AM
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attentional multi-level representation encoding based on convolutional and variance autoencoders for lncRNA-disease association prediction.
    Sheng N; Cui H; Zhang T; Xuan P
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32444875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNNDLP: A Method Based on Convolutional Autoencoder and Convolutional Neural Network with Adjacent Edge Attention for Predicting lncRNA-Disease Associations.
    Xuan P; Sheng N; Zhang T; Liu Y; Guo Y
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRlncRC: a machine learning-based method for cancer-related long noncoding RNA identification using integrated features.
    Zhang X; Wang J; Li J; Chen W; Liu C
    BMC Med Genomics; 2018 Dec; 11(Suppl 6):120. PubMed ID: 30598114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.
    Li Y; Chen J; Zhang J; Wang Z; Shao T; Jiang C; Xu J; Li X
    Oncotarget; 2015 Sep; 6(28):25003-16. PubMed ID: 26305674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDAEXC: LncRNA-Disease Associations Prediction with Deep Autoencoder and XGBoost Classifier.
    Lu C; Xie M
    Interdiscip Sci; 2023 Sep; 15(3):439-451. PubMed ID: 37308797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A machine learning framework that integrates multi-omics data predicts cancer-related LncRNAs.
    Yuan L; Zhao J; Sun T; Shen Z
    BMC Bioinformatics; 2021 Jun; 22(1):332. PubMed ID: 34134612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
    Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
    J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully connected autoencoder and convolutional neural network with attention-based method for inferring disease-related lncRNAs.
    Xuan P; Gong Z; Cui H; Li B; Zhang T
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35362511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learning global dependencies and multi-semantics within heterogeneous graph for predicting disease-related lncRNAs.
    Xuan P; Wang S; Cui H; Zhao Y; Zhang T; Wu P
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 36088549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
    Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer.
    Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C
    J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.